<tei>
    <teiHeader>
        <fileDesc xml:id="_Valovirta 2008.pdf"/>
    </teiHeader>
    <text xml:lang="en">


		<figure type="table">

            <table>2 Upper airway disease<lb/> </table>
<lb/> 
            <head>Table </head>
 
            <label>1 </label>
 
            <figDesc>Number of surveys and proportion of responders among the allergic rhinitis sufferers per country<lb/> </figDesc>
<lb/> 
            <table>Country<lb/> Number of collected<lb/> surveys<lb/> Estimated AR<lb/> sufferers a (millions)<lb/> % of AR population<lb/> in PVAS<lb/> % of responses<lb/> in PVAS<lb/> Belgium<lb/> 331<lb/> 1.7<lb/> 2.4<lb/> 9.2 b<lb/> Czech Republic<lb/> 272<lb/> 1.7<lb/> 2.4<lb/> 8.0 b<lb/> Finland<lb/> 364<lb/> 1.4<lb/> 2.0<lb/> 10.4 b<lb/> France<lb/> 302<lb/> 17.0<lb/> 24.4<lb/> 8.1 c<lb/> Germany<lb/> 186<lb/> 14.8<lb/> 21.3<lb/> 5.4 c<lb/> Greece<lb/> 87<lb/> 1.7<lb/> 2.4<lb/> 2.4<lb/> Italy<lb/> 294<lb/> 8.0<lb/> 11.5<lb/> 8.4 c<lb/> Netherlands<lb/> 199<lb/> 2.5<lb/> 3.6<lb/> 5.7 b<lb/> Spain<lb/> 561<lb/> 5.4<lb/> 7.8<lb/> 16.1 b<lb/> Switzerland<lb/> 222<lb/> 0.8<lb/> 1.2<lb/> 5.6 b<lb/> UK<lb/> 744<lb/> 14.7<lb/> 21.1<lb/> 20.8<lb/> Total<lb/> 3562<lb/> 69.7<lb/> 100<lb/> 100<lb/> a Taken from the Decision Resources Report 2001 (www.dresources.com/stellent/groups/public/documents/abstract/dr_008812.hcsp).<lb/> b Down-weighted countries (see text for explanation).<lb/> c Up-weighted countries (see text for explanation).<lb/> AR, allergic rhinitis; PVAS, Patient Voice Allergy Survey.</table>
		</figure>


		<figure type="table">

            <head>Table</head>

            <label>2 </label>
 
            <head>A </head>
 
            <figDesc>summary of the 26 survey questions<lb/> </figDesc>
<lb/> 
            <table>Background AR information<lb/> For how long have you had allergic rhinitis and who diagnosed<lb/> it first?<lb/> During which season, for how many days per week and during how<lb/> many consecutive weeks do you experience your AR symptoms?<lb/> What triggers your AR symptoms and how severe are they?<lb/> Impact of AR<lb/> How do your AR symptoms affect sleep, work, school, visiting<lb/> and/or meeting friends, travelling in public transport, indoor and<lb/> outdoor activities, choice of sport, choice of holiday destinations,<lb/> time of holidays?<lb/> How do your nasal and ocular symptoms affect you?<lb/> How does your AR affect you emotionally?<lb/> What are the three things that bother you most about your AR?<lb/> Did you take time off work/school because of your AR, over the<lb/> past year?<lb/> Have you ever been unable to concentrate at work/school, due<lb/> to your AR, over the past year?<lb/> Measures taken to ease AR symptoms<lb/> Have you had to make changes to your household, for<lb/> example purchasing special mattresses, pillows or duvets;<lb/> special household cleaning products; a humidifiers/air<lb/> cleaners; pollen screens; replaced existing furniture; removed<lb/> carpets? How effective were these measures?<lb/> How much money have you spent on making your home<lb/> allergy-free?<lb/> How many times a year do you visit your doctor because of<lb/> your AR?<lb/> Medications taken for AR<lb/> Do you take medications to prevent or control the AR symptoms<lb/> and how effective are they?<lb/> How do you obtain your medication (with or without prescription)?<lb/> AR and concomitant conditions<lb/> </table>
<lb/> 
            <note>Do you suffer from asthma, atopic eczema, urticaria, or food allergy<lb/> and if so does your AR worsen them?<lb/> Have you ever approached your doctor about your asthma/eczema/<lb/> urticaria/food allergy?<lb/> Severity was measured on a scale of 0 (none) to 3 (severe).<lb/> AR, allergic rhinitis.</note>
		</figure>


		<figure type="table">

            <figDesc>Allergic rhinitis Valovirta et al. 3<lb/> </figDesc>
<lb/> 
            <table>Figure 1 Duration of allergic rhinitis in Europe (percentage of<lb/> patients)<lb/> 22%<lb/> 22%<lb/> 31%<lb/> 24%<lb/> 0-5 years;<lb/> 6-10 years;<lb/> 11-20 years;<lb/> all your life.<lb/> Figure 2 Time of year when allergic rhinitis symptoms are most<lb/> bothersome (percentage of patients)<lb/> 50%<lb/> 26%<lb/> 7%<lb/> 15%<lb/> 2%<lb/> One season;<lb/> two seasons;<lb/> three seasons;<lb/> four seasons;<lb/> not stated.</table>
		</figure>


		<figure type="table">

            <head>Table</head>

            <label>3 </label>
 
            <figDesc>Allergic rhinitis symptom severity and symptom distribution over various disease types and sexes<lb/> </figDesc>
<lb/> 
            <table>Severity of AR symptoms (%)<lb/> Type of AR (%)<lb/> Sex (%)<lb/> Absent<lb/> Mild<lb/> Moderate<lb/> Severe<lb/> PER<lb/> IAR<lb/> Male<lb/> Female<lb/> Runny nose<lb/> 10<lb/> 16<lb/> 44<lb/> 30<lb/> 34<lb/> 24<lb/> 32<lb/> 28<lb/> Sneezing<lb/> 10<lb/> 22<lb/> 42<lb/> 26<lb/> 29<lb/> 22<lb/> 27<lb/> 26<lb/> Blocked nose<lb/> 19<lb/> 18<lb/> 34<lb/> 30<lb/> 34<lb/> 24<lb/> 32<lb/> 27<lb/> Itchy/red eyes<lb/> 29<lb/> 21<lb/> 29<lb/> 21<lb/> 26<lb/> 13<lb/> 24<lb/> 16<lb/> Itchy nose<lb/> 22<lb/> 27<lb/> 34<lb/> 17<lb/> 19<lb/> 13<lb/> 18<lb/> 14<lb/> Wheezing/coughing<lb/> 42<lb/> 22<lb/> 20<lb/> 16<lb/> 19<lb/> 12<lb/> 19<lb/> 11<lb/> Watery eyes<lb/> 40<lb/> 24<lb/> 23<lb/> 12<lb/> 15<lb/> 9<lb/> 14<lb/> 9<lb/> Itchy throat<lb/> 43<lb/> 26<lb/> 20<lb/> 11<lb/> 13<lb/> 6<lb/> 14<lb/> 5<lb/> Itchy palate/ears<lb/> 46<lb/> 23<lb/> 21<lb/> 10<lb/> 13<lb/> 5<lb/> 14<lb/> 3<lb/> </table>
<lb/> 
            <note>AR, allergic rhinitis; IAR, intermittent allergic rhinitis; PER, persistent allergic rhinitis.</note>
		</figure>


		<figure type="table">

            <table>Figure 3 Main triggers of allergic rhinitis<lb/> 17%<lb/> 16%<lb/> 17%<lb/> 19%<lb/> 23%<lb/> 26%<lb/> 31%<lb/> 51%<lb/> 71%<lb/> 24%<lb/> 25%<lb/> 26%<lb/> 27%<lb/> 29%<lb/> 33%<lb/> 39%<lb/> 61%<lb/> 77%<lb/> Cleaning products<lb/> Food<lb/> Feathers<lb/> Perfume<lb/> Mould<lb/> Tobacco smoke<lb/> Animals<lb/> Dust<lb/> Plants/flowers<lb/> 11%<lb/> 16%<lb/> 15%<lb/> 17%<lb/> 17%<lb/> 20%<lb/> 30%<lb/> 50%<lb/> 77%<lb/> 26%<lb/> 25%<lb/> 26%<lb/> 28%<lb/> 31%<lb/> 35%<lb/> 39%<lb/> 61%<lb/> </table>
<lb/> 
            <note>74%<lb/> Comparisons are shown for persistent and intermittent allergic rhinitis, and for female and male patients. Percentages of patients are given.<lb/> Persistent (n ¼ 2305);<lb/> Intermittent (n ¼ 1257);<lb/> Females (n ¼ 2287);<lb/> Males (n ¼ 1129).<lb/> </note>
<lb/> 
            <table>Figure 4 Effect of persistent and intermittent allergic rhinitis on<lb/> sleep (percentage of patients)<lb/> 52%<lb/> 49%<lb/> 32%<lb/> 35%<lb/> 24%<lb/> 35%<lb/> Not feeling rested<lb/> upon waking<lb/> Disturbed sleep<lb/> waking in night<lb/> Difficulty getting to<lb/> sleep<lb/> Patients with<lb/> moderate to<lb/> severe impact (%)<lb/> </table>
<lb/> 
            <note>Persistent (n ¼ 2305);<lb/> intermittent (n ¼ 1257).</note>
		</figure>


		<figure type="table">

            <table>5 times a<lb/> year compared with 2.4 times for IAR patients. Almost<lb/> half of the diagnoses are made by GPs (48%), and 32%<lb/> by allergy and ear, nose and throat specialists. A high<lb/> proportion of allergic rhinitis patients take medications<lb/> to either prevent (77%) or control (88%) their symp-<lb/>toms. Antihistamines are the most widely used. For the<lb/> control of rhinitis symptoms, 18% of patients use anti-<lb/>histamines alone, 11% used them in combination with<lb/> nasal steroids and 11% use antihistamines together<lb/> with nasal steroids and eye drops. Only 5% of patients<lb/> use nasal steroids alone.<lb/> Medication use is higher among PER patients compared<lb/> to those with IAR. Antihistamines are used by 75% of<lb/> Allergic rhinitis Valovirta et al. 5<lb/> Figure 5 Impact of persistent and intermittent allergic rhinitis on daily activities (percentage of patients)<lb/> 61%<lb/> 56%<lb/> 48%<lb/> 41%<lb/> 37%<lb/> 42%<lb/> 33%<lb/> 33%<lb/> 28%<lb/> 52%<lb/> 21%<lb/> 29%<lb/> 19%<lb/> 32%<lb/> 24%<lb/> 32%<lb/> 31%<lb/> 40%<lb/> Outdoor<lb/> activities<lb/> Visiting<lb/> Going out<lb/> Sleep<lb/> Work*<lb/> friends<lb/> Sport/<lb/> exercise<lb/> Holiday<lb/> dest.<lb/> Indoor<lb/> activities<lb/> Public<lb/> transport<lb/> Patients with<lb/> moderate to<lb/> severe impact (%)<lb/> Persistent (n ¼ 2305);<lb/> Intermittent (n ¼ 1257).<lb/> </table>
<lb/> 
            <note>Ã Only for working patients (n ¼ 2287).<lb/> </note>
<lb/> 
            <table>Table 4 Impact of allergic rhinitis on daily activities<lb/> Percentage of patients<lb/> Frequently<lb/> affected (%)<lb/> Affected all<lb/> the time (%)<lb/> Outdoor activities<lb/> 34<lb/> 24<lb/> Work a<lb/> 36<lb/> 13<lb/> Sleep<lb/> 29<lb/> 12<lb/> School b<lb/> 25<lb/> 9<lb/> Meeting friends in bar/restaurant<lb/> 23<lb/> 15<lb/> Visiting friends&apos; houses<lb/> 25<lb/> 8<lb/> Choice of sport/exercise<lb/> 25<lb/> 13<lb/> Choice of holiday destination<lb/> 17<lb/> 11<lb/> Indoor activities<lb/> 25<lb/> 7<lb/> Travelling on public transport<lb/> 19<lb/> 6<lb/> Time of holiday<lb/> 15<lb/> 10<lb/> </table>
<lb/> 
            <note>a Working: n ¼ 2287.<lb/> <note>b Studying: n ¼ 376.<lb/> </note>
<lb/> 
            <table>Figure 6 Emotional impact of allergic rhinitis across Europe<lb/> (percentage of patients)<lb/> 16%<lb/> 22%<lb/> 23%<lb/> 39%<lb/> 31%<lb/> 29%<lb/> 31%<lb/> 28%<lb/> 31%<lb/> 32%<lb/> 30%<lb/> 18%<lb/> 22%<lb/> 17%<lb/> 15%<lb/> 17%<lb/> Tired/worn<lb/> out<lb/> Irritable/<lb/> frustrated<lb/> Poor<lb/> concentration<lb/> Embarrassed<lb/> by appearance<lb/> Absent;<lb/> mild;<lb/> moderate;<lb/> Severe.</table>
		</figure>



    </text>
</tei>

